Call Us Today! 256-236-0055
GET STARTED

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals is a biopharmaceutical company focused on the development of breakthrough treatments for human disease. We have advanced multiple drug candidates into clinical development. We are presently devoting most of our resources to the development of our two most advanced drug candidates, LX4211  for the treatment of type 1 and type 2 diabetes and Telotristat etiprate (LX1032/LX1606) for the treatment of carcinoid syndrome. -- About Us